In dangerous drugs news, a newly released study supports claims that Risperdal can result in gynecomastia in boys and young men. “Gynecomastia” is the medical term for male breast enlargement. This condition can result in serious psychological trauma and painful surgery to remove excess breast tissue.
In August 2015, the result of a new study was published in the Journal of Child and Adolescent Psychopharmacology. Researchers from the University of British Columbia found that use of Risperdal in teens and young men may increase the chance of gynecomastia by four times. Researchers evaluated a database of more than 400,000 teens and young men. The data revealed 1,556 instances of gynecomastia. Researchers concluded that Risperdal users were 3.91 times more likely to experience gynecomastia when compared to young men who did not use the drug. In teens under the age of 18, reseachers found that the risk of developing gynecomastia increased by more than five times.
One of the researchers stated “Our study showed a strong association between risperidone use and gynecomastia in young adult males. Clinicians who are prescribing risperidone to this demographic may need to consider this adverse event in their therapeutic decision-making process.”
Risperdal is an antipsychotic medication manufactured by Johnson & Johnson. It is used to treat schizophrenia, bipolar disorder and some autistic conditions.
The Ohio pharmaceutical injury attorneys at Clark, Perdue & List are investigating claims for personal injury caused by use of Risperdal. If you or a loved one has developed gynecomastia due to use of Risperdal, you may have a claim. Clark, Perdue & List have represented hundreds of people who have been injured by dangerous drugs.